Paul Walker Biography and Net Worth

Major Shareholder of Metacrine


Currently, Paul E. Walker is General partner for NEA Management Co. LLC.

He is also on the board of Allakos, Inc.

In the past he held the position of Portfolio Manager at Franklin Resources, Inc. and Portfolio Manager at Franklin Templeton Investments Corp. (a subsidiary of Franklin Resources, Inc.) and Partner at MPM BioEquities Adviser LLC.

He received an undergraduate degree from the University of California San Diego.

What is Paul Edward Walker's net worth?

The estimated net worth of Paul Edward Walker is at least $1.97 million as of September 21st, 2022. Mr. Walker owns 3,386,400 shares of Metacrine stock worth more than $1,968,853 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Walker may own. Learn More about Paul Edward Walker's net worth.

How do I contact Paul Edward Walker?

The corporate mailing address for Mr. Walker and other Metacrine executives is 3985 SORRENTO VALLEY BLVD. SUITE C, SAN DIEGO CA, 92121. Metacrine can also be reached via phone at 858-369-7800 and via email at [email protected]. Learn More on Paul Edward Walker's contact information.

Has Paul Edward Walker been buying or selling shares of Metacrine?

Paul Edward Walker has not been actively trading shares of Metacrine during the past quarter. Most recently, Paul Edward Walker sold 459,700 shares of the business's stock in a transaction on Wednesday, December 22nd. The shares were sold at an average price of $0.97, for a transaction totalling $445,909.00. Learn More on Paul Edward Walker's trading history.

Who are Metacrine's active insiders?

Metacrine's insider roster includes Hubert Chen (Insider), Preston Klassen (CEO), and Paul Walker (Major Shareholder). Learn More on Metacrine's active insiders.

Paul Edward Walker Insider Trading History at Metacrine

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2021Sell459,700$0.97$445,909.00View SEC Filing Icon  
12/10/2021Sell37,570$1.32$49,592.40View SEC Filing Icon  
See Full Table

Paul Edward Walker Buying and Selling Activity at Metacrine

This chart shows Paul Edward Walker's buying and selling at Metacrine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Metacrine Company Overview

Metacrine logo
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.58
Low: $0.58
High: $0.59

50 Day Range

MA: $0.57
Low: $0.55
High: $0.59

2 Week Range

Now: $0.58
Low: $0.30
High: $0.59

Volume

83,889 shs

Average Volume

225,834 shs

Market Capitalization

$24.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A